HemoHIM – What is it?



Patented in the United States, 4 major countries of Europe, as well as Korea, HemoHIM is continually proving its effect in immunity enhancement.

HEMOHIM is a new substance with special immune function that has been developed from Angelica radix, Chuanxiong Rhizoma, and PaeoniaenAlba Radix through biological engineering and radiation technology. Safety and function has been proven through clinical tests, and has been approved by the KFDA as the very first health functional supplement assisting functions of the immune system.

HemoHIM Development

Food & Biotechnology Team of Korea Atomic Energy Research Institute (KAERI)
Development of Functional Biodefense Food for people dealing with radiation
  (KAERI Food & Biotechnology Team/Korea Cancer Center Hospital)
Development of the new substance HemoHIM, which helps with Immunity enhancement (Proven through numerous tests)

Animal Experiment

HemoHIM mixed herbal extracts improved the recovery and survival rate of animals with reduced levels of white blood cells and lymphocytes in the peripheral blood. Oral administration of HemoHIm into animals with deficient immunity resulted in significant recovery of the number of white blood cells and lymphocytes, as well as NK cell activation.

Human Body Experiment

63 people with less than 5000/ul of white blood cells took HemoHIM mixed herbal extracts and experienced enhanced NK cell, cytokine, and immunocyte activity. * Human based data may vary according to individual constitution.

HemoHIM Development

Kolmar BNH Co. Ltd. (SBT) was established in Daeduk Research and Development Special Zone, the first research enterprise approved by the Ministry of Education, Science and Technology in Korea (Kolmar BNH (SBT) is a joint venture between the KAERI and Kolmar Korea)
Passed the Individually Approved Type evaluation of MFDS
Sales commercialization through Atomy Co. www.atomy.kr